NCT05736757View on ClinicalTrials.gov

Application of tPA in Suprachoroidal and Subretinal Hemorrhage

NARecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

December 1, 2022

Primary Completion Date

April 1, 2023

Study Completion Date

July 31, 2026

Conditions
Ocular Trauma
Interventions
DRUG

Tissue Plasminogen Activator

Injection of 50 ug tissue plasminogen activator into the suprachoroidal cavity or subretinal space to assist in bleeding liquefaction

Trial Locations (1)

310009

RECRUITING

Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou

All Listed Sponsors
lead

Second Affiliated Hospital, School of Medicine, Zhejiang University

OTHER